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Attempts to create mouse models for AIDS have been hampered by species barriers in
HIV-1 infection.Wepreviously showed that the nuclear accumulation ofHIV-1 preintegration
complex (PIC) was suppressed in mouse cells. Lens epithelium-derived growth factor
(LEDGF/p75) is a host factor identiﬁed as a binding partner of integrase (IN), and has been
suggested to be involved in promoting viral integration by tethering PIC to the chromatin,
which are observed as nuclear accumulation of IN by LEDGF/p75. Therefore, we here
hypothesized that this host factor might act as one of the species-speciﬁc barriers inmouse
cells.We generated transgenic (Tg) mice that constitutively express human (h) LEDGF/p75.
The GFP-fused IN was efﬁciently accumulated into the nucleus of hLEDGF/p75 expressing
Tgmouse embryonic ﬁbroblast (MEF) cells in contrast to the control MEF cells. Importantly,
hLEDGF/p75 Tg MEF cells were signiﬁcantly more susceptible to HIV-1 infection. These
results suggest that LEDGF/p75 is one of the host factors that constitute species barrier
against HIV-1 in mouse cells.
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INTRODUCTION
The number of patients with HIV/AIDS has been increasing
throughout the world. In order to study AIDS pathogenesis and
to evaluate antiviral drugs and vaccines, animal models for HIV-1
infection need to be established. A mouse model has been con-
sidered as one of such candidates because of the availability of
inbred and gene-manipulated strains. As a matter of fact, mice
are non-permissive for HIV-1 infection because of the species bar-
riers against both the early, and late phases of HIV-1 infection
(van Maanen and Sutton, 2003), although the precise mecha-
nisms for the non-permissiveness remain unclear. The ﬁnding
that the heterokaryons created between human and mouse cells
were susceptible to HIV-1 infection (Dragic et al., 1992; Mariani
et al., 2001) suggested that mouse cells lack some human-speciﬁc
cofactors that can support HIV-1 replication.
A number of factors in host cells have been implicated to be
involved in the early and late phases of HIV-1 infection; e.g., CD4
as the major receptor for HIV-1 entry (Maddon et al., 1985; Lores
et al., 1992), chemokine receptors as coreceptors (Berson et al.,
1996; Feng et al., 1996) and cyclin T1 (CycT1) for the efﬁcient
viral transcription through binding to HIV-1 Tat (Bieniasz et al.,
1998;Wei et al., 1998). However, several Tg mice lines that express
human versions of CD4, either CXCR4 (hCD4/hCXCR4/hCycT1
Tg) or CCR5 (hCD4/hCCR5/hCycT1 Tg), and CycT1 did not
efﬁciently support HIV-1 replication despite HIV-1 entry and
reverse transcription proceeded normally (Browning et al., 1997;
Sawada et al., 1998; Mariani et al., 2000). On the other hand, Tg
mice carrying the pol gene-deleted HIV-1 proviral genome (HIV-
Tg), which we previously generated, were able to not only express
all viral mRNA species, including unspliced, singly spliced, and
multiply spliced mRNAs, but also produce high levels of gag p24
antigen, after treatment with bacterial lipopolysaccharides (LPS)
(Iwakura et al., 1992). Taken together, these results indicate that
once the viral genome is efﬁciently integrated into the host chro-
mosome, viral genes are expressed normally, and that unknown
species barriers inmice are still present in the early phase of HIV-1
infection.
HIV-1 preintegration complex (PIC) is composed of newly
synthesized viral cDNA and several host and viral proteins, the
latter of which include integrase (IN), reverse transcriptase (RT),
matrix (MA) and Vpr. The PIC is actively accumulated into the
nucleus. We previously showed that the nuclear accumulation
of GFP-fused IN (GFP-IN) was signiﬁcantly reduced in mouse
cells than in human cells (Tsurutani et al., 2007), suggesting that
inefﬁcient PIC nuclear accumulation in mouse cells might be
attributed to the inability of IN to interact with host factors. Lens
epithelium-derived growth factor (LEDGF) could be one of such
candidates in that it can associate with IN and mediate HIV-1
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nuclear accumulation and integration into the chromosome in
human cells (Maertens et al., 2003). LEDGF is translated into two
proteins, p75 and p52, as a result of alternative splicing (Ge et al.,
1998a). LEDGF/p75, but not p52, can associate with IN through
its IN-binding domain (IBD; Ge et al., 1998b). Moreover, IN and
LEDGF/p75 co-localize in the nucleus of human cells, and recom-
binant LEDGF/p75 robustly enhances strand transfer activity of
IN in vitro (Singh et al., 1999). It was also shown that RNAi-
mediated knockdown of endogenous LEDGF/p75 abolished IN
nuclear accumulation, HIV-1 integration and HIV-1 production
(Maertens et al., 2003; Llano et al., 2004b; Ciufﬁ et al., 2005).
LEDGF/p75 is also known as a critical factor for the selection of
integration sites such as promoter regions and CpG islands. Thus,
LEDGF/p75 has been suggested to be one of important host factors
at the PIC nuclear accumulation and integration steps (Bukrinsky,
2004; Llano et al., 2004a, 2006a; Emiliani et al., 2005; Maillot et al.,
2013).
In this study, we ﬁrst created expression plasmids encoding
human and mouse LEDGF/p75 (hLEDGF/p75 or mLEDGF/p75,
respectively) to compare their ability to support HIV-1 infec-
tion in mouse embryonic ﬁbroblast (MEF) cells, and found that
the expression of hLEDGF/p75 rendered MEF cells more sensi-
tive to HIV-1 infection than that of mLEDGF/p75. Moreover,
we generated hLEDGF/p75 transgenic (hLEDGF/p75 Tg) mice
and examined if the expression of hLEDGF/p75 could relieve
the species barrier of HIV-1 infection in mouse cells. Trans-
genic expression of hLEDGF/p75 enhanced IN accumulation in
the nucleus and HIV-1 infection in mouse cells, suggesting that
LEDGF/p75 is one of the host factors that may determine a species
barrier against HIV-1 in mouse cells. We therefore conclude that
the transgenic introduction of hLEDGF/p75 would be helpful to
generate a small animal model that could be more permissive to
HIV-1 infection.
MATERIALS AND METHODS
CELLS
HeLa, 293T, and MT4 cells were obtained from ATCC (Rockville,
USA), the RIKEN Cell Bank (Ibaraki, Japan), and the Health
Science Research Resources Bank (Osaka, Japan), respectively.
MEF cells from LEDGF/p75 Knockout mice were kindly pro-
vided by A. Engelman (Shun et al., 2007). HeLa, 293T, and MEF
cells were maintained in Dulbecco’s modiﬁed Eagle’s medium
(DMEM; Life Technologies, NY, USA) supplemented with 10%
fetal bovine serum (FBS). MT4 cells were maintained in RPMI
1640 medium (Life Technologies, NY, USA) supplemented with
10% FBS.
PLASMIDS
Env-deﬁcient HIV-1 proviral indicator construct pNL-Luc-E-R+,
a vesicular stomatitis virus G (VSV-G)-expressing plasmid
pHIT/G, and an HIV-1 NL-Env expression plasmid pNLnBS
(Tokunaga et al., 1998) were described previously (Fouchier et al.,
1997; Tokunaga et al., 2001). The expression vector for a codon-
optimized HIV-1 IN fused N-terminally to GFP (GFP-IN) was
previously constructed (Tsurutani et al., 2007). The hLEDGF/p75
transgene was constructed as follows. hLEDGF/p75 cDNA was
obtained fromHeLa cells using SuperScript First-Strand Synthesis
System (Invitrogen, CA, USA). A 1.6 kb hLEDGF/p75 fragment
was ampliﬁed by PCR with KOD-Plus- (TOYOBO,Osaka, Japan).
The primer pairs used to amplify hLEDGF/p75 fragments were
as follows: forward primer 5′-ACG AAT TCG CCA CCA TGA
CTC GCG ATT TCA AAC CTG GAG ACC-3′, reverse primer
5′-CCG AAT TCT CAG TTA TCT AGT GTA GAA TCC TTC
AGA GAT ATT TCA G-3′, that have EcoRI site, Kozak sequence
respectively. PCR product was digested with EcoRI and inserted
into pCAGGS mammalian expression vector (Niwa et al., 1991).
Similarly, C-terminally HA-tagged versions of these plasmids
were created by using pCAGGS-3HA expression vector (Iwabu
et al., 2009). To generate CD4/CXCR4 expression plasmid, CD4,
CXCR4, and ECMV IRES were PCR-ampliﬁed from pNL-CD4,
pNL-CXCR4 (Tokunaga et al., 2001), and pIRESpuro2 (Clon-
tech, CA, USA), and then digested with KpnI/XhoI, XhoI/NotI,
and NotI, respectively. Digested fragments were inserted into
pCAGGS and the resultant expression plasmid was designated
pCa-CD4/CXCR4.
TRANSFECTIONS AND PROTEIN ANALYSES
5 × 105 293T cells were transfected with 0.5 μg of either
hLEDGF/p75 or mLEDGF/p75 expression plasmid by using
FuGENE6 transfection reagent (Promega, Wisconsin, USA), and
grown for 48 h. Cell extracts were subjected to gel electrophoresis
and then transferred to a nitrocellulose membrane. The mem-
branes were probed with an anti-HA antibody (BD biosciences,
NJ, USA). Reacted proteins were visualized by chemiluminescence
using an ECL Western blotting detection system (GE Healthcare,
Little Chalfont, UK) and monitored using a LAS-3000 imaging
system (FujiFilm, Tokyo, Japan).
INFECTION OF MEF CELLS TRANSIENTLY EXPRESSING LEDGF/p75 WITH
HIV-1 REPORTER VIRUSES
2.5× 105 MEF cells derived fromLEDGF/p75 knockoutmice were
cotransfected with 0.5 μg of either hLEDGF/p75 ormLEDGF/p75
expression plasmid, 0.5 μg of pCa-CD4/CXCR4, and 5 ng
of phRL-TK Renilla luciferase expression plasmid (Promega)
by using Lipofectamine with Plus reagents (Life Technologies)
and grown for 48 h. Infection experiments were performed as
described below. Viruses were prepared by cotransfecting 293T
cells with 1 μg of pNL-Luc-E-R+, 0.5 μg of pNLnBS, and
0.5 μg of an empty plasmid by using FuGENE6. After 48 h,
the supernatants were treated with 37.5 units/ml DNase I (Roche
Applied Science, MD, USA) for 37◦C for 30 min and then har-
vested, and the amount of p24 antigen was measured by using
an HIV-1 p24-antigen capture enzyme-linked immunosorbent
assay (ELISA) (Advanced BioScience Laboratories, CA, USA).
1 × 104 MEF cells transiently expressing either hLEDGF/p75 or
mLEDGF/p75 were infected with 1 ng of p24 antigen of HIV-
1 reporter viruses. At 48 h after infection, cells were lysed with
Passive Lysis Buffer (Promega). Cell lysates were subjected to
the luciferase assay using the Dual Luciferase Reporter Assay
Systems (Promega). Luciferase activity was measured by Cen-
tro LB 960 Microplate Luminometer (Berthold Technologies, Bad
Wildbad, Germany). Values were normalized by Renilla luciferase
activity.
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GENERATION OF hLEDGF/p75 Tg MICE
The hLEDGF/p75 trangene was digested with BamHI-HindIII,
puriﬁed from agarose gel with GeneClean Kit (MP-Biomedicals,
CA, USA) and adjusted to a ﬁnal concentration of 5 × 105
copies/μl (2.13 ng/μl). Puriﬁed fragments were injected into the
male pronuclei of fertilized mouse embryos (C3H/HeN; CLEA
Japan Inc, Tokyo, Japan). Mice were kept under speciﬁc-pathogen-
free conditions in an environmentally controlled clean room at the
Center for Experimental Medicine and Systems Biology, the Insti-
tute of Medical Science, the University of Tokyo. All experiments
were done according to the ethical guidelines for animal experi-
mentation, which was approved by the Institutional Review Board
of the Institute of Medical Science, the University of Tokyo.
SOUTHERN BLOT HYBRIDIZATION
Southern blot analyses were carried out as previously described
(Smith and Murphy, 1993). Genomic DNA (10 μg) extracted
from the mouse tails was digested with PstI. Digested DNA
was electrophoresed and blotted onto a membrane. Membrane
was hybridized with 32P labeled probe. To detect hLEDGF/p75,
an EcoRI-PstI (540 bp) fragment from pCAGGS was used as
a β-globin probe. The autoradiograms were developed and the
band intensity was quantiﬁed by a BAS 2000 Bio-Image analyzer
(FujiFilm, Tokyo, Japan). Alpha-fetoprotein (AFP) was used as an
internal control.
NORTHERN BLOT HYBRIDIZATION
Total RNA from the thymus, spleen, lymph nodes and thio-
glycolate (TGC)-elicited macrophages of hLEDGF/p75 Tg mice
was prepared by the acid guanidium thiocyanate phenol chloro-
formmethod (Chomczynski and Sacchi, 1987). In order to obtain
macrophages,micewere injected intraperitoneallywith 2ml of 4%
TGC (Difco Laboratories, MI, USA). Three days later, peritoneal
exudate cells were collected (Saijo et al., 2007). Northern blot anal-
yses were carried out as previously described (Yasuda et al., 2001).
hLEDGF/p75 probe (1.6 kb) was generated by PCR with KOD-
Plus- by using the following primers: forward primer; 5′-ACG
AAT TCG CCA CCA TGA CTC GCG ATT TCA AAC CTG GAG
ACC-3′, reverse primer; 5′-CCG AAT TCT CAG TTA TCT AGT
GTA GAA TCC TTC AGA GAT ATT TCA G-3′. The autoradio-
grams were developed, and the radioactivity of each the bands was
quantiﬁed with the BAS 2000 Bio-Image analyzer (FujiFilm).
REAL-TIME RT-PCR
Total RNA from MEF cells was extracted using ReliaPrep RNA
Cell Miniprep System (Promega) according to the manufacturer’s
instructions. Real-time RT-PCR was performed using One Step
SYBRPrimeScript RT-PCRKit (Takara, Shiga, Japan)with theABI
PRISM7900HTSequenceDetection System. hLEDGF/p75mRNA
was detected by using the following primers: forward primer;
5′-GAG AAA CAT CAA TGG ATT CTC GAC-3′ and reverse
primer; 5′-CTC AAT GCA TCT GTT CAC ATC AAG-3′. GAPDH
was detected by using the following primers: forward primer; 5′-
GAT GCT GGC GCT GAG TAC G-3′ and reverse primer; 5′-GCA
GAGATGATGACC CTT TTG-3′. Levels of hLEDGF/p75 mRNA
were normalized with those of GAPDH mRNA.
PREPARATION OF MEF CELLS EXPRESSING hLEDGF/p75
Mouse embryonic ﬁbroblast cells from hLEDGF/p75 Tg and
wild-type (WT) mice were prepared as follows. Fetuses were
harvested at 13.5 days of gestation. Embryonic internal organs
were removed from the abdominal cavity using dissecting forceps.
The embryos were transferred to a 10 cm dish containing 10 ml
trypsin/EDTA solution and incubated 20 min at 37◦C. After
trypsinization, cells were washed and cultured in DMEM. Cell
extracts were subjected to gel electrophoresis and then trans-
ferred to a nitrocellulosemembrane. Themembranes were probed
with an anti-hLEDGF/p75 antibody (BD biosciences, NJ, USA).
Reacted proteins were visualized by chemiluminescence using an
ECL Western blotting detection system and monitored using a
LAS-3000 imaging system.
FLUORESCENCE MICROSCOPY
One day prior to transfection, 2 × 105 HeLa, and MEF cells were
plated in 8 well culture slides (Nalgene Nunc International, NY,
USA) and transfectedwith 0.8μg of DNA (GFP-IN) per well using
Lipofectamine 2000 (Invitrogen). After 6 h, medium was replaced
with fresh culture medium. Forty eight hours post-transfection,
cells were washed once in PBS and ﬁxed with acetone for 5 min.
After washing with PBS, 1μg/ml of Hoechst suspended in PBSwas
added. After 10 min incubation, cells were covered by a coverslip.
Confocal microscopy was performed with a Nikon Optiphot-2
ﬂuorescence microscope with a Bio-Rad MRC 1024 laser confocal
imaging system (Nikon, Tokyo, Japan).
INFECTION OF hLEDGF/p75 Tg MEF CELLS WITH VSV-G-PSEUDOTYPED
HIV-1 REPORTER VIRUSES
The VSV-G pseudotyped NL4-3-Luc viruses were produced by
cotransfecting 293T cells with 1.9 μg of pNL-Luc-E-R+ and
0.1 μg of pHIT/G by using FuGENE6. After 48 h, the super-
natants were treated with DNase I for 37◦C for 30 min and
then harvested, and the amount of p24 antigen was mea-
sured by using an HIV-1 p24-antigen capture ELISA. 1 × 104
hLEDGF/p75 Tg MEF cells (No. 089, 110, and 143) were
infected with 200 pg of p24 antigen of VSV-G-pseudotyped
HIV-1 reporter viruses. At 48 h after infection, cells were lysed
with Passive Lysis Buffer and subjected to the luciferase assay.
Luciferase activity was measured by Centro LB 960 Microplate
Luminometer.
RESULTS
FUNCTIONAL DIFFERENCE BETWEEN HUMAN AND MURINE LEDGF/p75
PROTEINS
We previously showed that the nuclear accumulation of PIC was
blocked in mouse cells (Tsurutani et al., 2007), suggesting that
mLEDGF/p75 might be defective at this step. To test this hypoth-
esis, we created HA-tagged hLEDGF/p75 and mLEDGF/p75
expression plasmids. Protein expressions in the cells transfected
with each plasmid were conﬁrmed by immunoblotting using anti-
HA antibodies (Figure 1A). We cotransfected MEF cells derived
from LEDGF/p75 knockout mice with either hLEDGF/p75 or
mLEDGF/p75, together with CD4/CXCR4 expression plasmid.
We then examined the efﬁciency of HIV-1 infection by usingMEF
cells transiently expressing hLEDGF/p75 or mLEDGF/p75. We
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FIGURE 1 | Comparison of hLEDGF/p75 and mLEDGF/p75 in the ability
to support HIV-1 infection. (A) Detection of hLEDGF/p75 and
mLEDGF/p75 proteins. 293T cells were transfected with either
hLEDGF/p75 or mLEDGF/p75 expression plasmid and grown for 48 h.
Western blot was performed to detect LEDGF/p75 proteins by using an
anti-HA antibody. β-actin was used as an internal control. (B) HIV-1
infectivity in cells expressing different LEDGF/p75 proteins. MEF cells
derived from LEDGF/p75 knockout (KO) mice were cotransfected with
either hLEDGF/p75 or mLEDGF/p75 expression plasmid, pCa-CD4/CXCR4,
and phRL-TK Renilla luciferase expression plasmids, and grown for 48 h.
MEF cells transiently expressing either hLEDGF/p75 or mLEDGF/p75 were
infected with HIV-1 reporter viruses. At 48 h after infection, cells were
subjected to the luciferase assay. Values were normalized with Renilla
luciferase activity. *P < 0.01 (t -test).
found that infection was more efﬁcient in MEF cells expressing
hLEDGF/p75 than those expressing mLEDGF/p75 (Figure 1B).
These results suggest that hLEDGF/p75 expression renders MEF
cells more susceptible to HIV-1 infection.
GENERATION OF TRANSGENIC MICE CARRYING THE hLEDGF/p75
We generated Tg mice carrying the hLEDGF/p75 to examine
whether the host factor would be able to confer HIV-1 suscep-
tibility to the animals. To obtain Tg mice expressing high levels
of hLEDGF/p75 in multiple tissues, a transgene consisting of
the cytomegalovirus immediate-early enhancer/chicken β-actin
promoter, the hLEDGF/p75 cDNA and rabbit β-globin poly A,
was constructed (Figure 2A). Transgenic founders were obtained
by microinjecting the transgene into the pronuclei of fertilized
FIGURE 2 | Generation of hLEDGF/p75Tg mice. (A) Construction of the
transgene. hLEDGF/p75 gene (white box) was ligated downstream of the
CMV-immediate-early enhancer/chicken β-actin promoter (CAG) promoter.
Restriction enzyme sites are indicated as follows: Hind III (HIII), EcoRI (EI)
and Pst I (PI). (B) Detection of the transgene in hLEDGF/p75Tg mice by
Southern blot hybridization analysis. Cellular DNA (10 μg) was extracted
from the mouse tails, digested with PstI, and was electrophoresed in an
agarose gel. β-globin poly A was used as a probe (black box). Cellular DNA
fromWT mouse was used as a negative control (WT), andWT DNA
containing pCAGGS-hLEDGF/p75 plasmid copies was used as a positive
control (Pos). Alpha-fetoprotein (AFP) was used as an internal control. The
sizes expected for hLEDGF/p75 and AFP are indicated by arrowheads.
embryos from WT parents (C3H/HeN). Southern blot hybridiza-
tion was carried out to detect the transgene by using a probe
speciﬁc for β-globin polyA. Out of 165 offspring, we obtained
9 transgenic founder mice in which the hLEDGF/p75 transgene
was integrated (Figure 2B).
hLEDGF/p75 TRANSGENE EXPRESSION IN hLEDGF/p75 Tg MICE
In order to analyze the expression of hLEDGF/p75 mRNA in
hLEDGF/p75 Tg F1 mice, Northern blot hybridization was per-
formed by using total RNAs puriﬁed from thymus, spleen, lymph-
nodes, and TGC-elicited macrophages. As shown in Figure 3A,
1.7 kb bands were detected in hLEDGF/p75 Tg mice, while the
endogenous 2.1 kb bands were detected in HeLa and MT4 cells.
hLEDGF/p75 mRNA from line No. 089 Tg mouse was detected
in all the tissues, in which levels of hLEDGF/p75 expression was
similar to those in HeLa orMT4 cells. ThemRNAwas also present
in the thymus and spleen derived from the line No. 110 Tg mouse,
in the thymus, spleen and lymph-nodes of the line No. 143 Tg
mouse (Figures 3A,B). Either the line No. 004, 005, 008, 015, and
062 Tg mice or the line No. 129 Tg mice expressed only in the
thymus or lymph-nodes, respectively (data not shown). For fur-
ther studies, we thus selected 3 lines (line No. 089, 110, and 143
Tg mice) expressing relatively high hLEDGF/p75 mRNA in the
thymus, spleen and lymph nodes.
ESTABLISHMENT OF MEF CELLS DERIVED FROM hLEDGF/p75 Tg MICE
To investigate whether hLEDGF/p75 promotes IN nuclear accu-
mulation, we examined the subcellular localization of IN in
hLEDGF/p75 Tg mouse cells. We generated MEF cells from
hLEDGF/p75 Tg mice and the expression of hLEDGF/p75 was
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FIGURE 3 | hLEDGF/p75 expression inTg mice. (A)Total RNA was
extracted from the thymus (Thy), spleen (Sp), lymph-nodes (LN), and
TGC-elicited macrophages from hLEDGF/p75Tg mice. Northern blot
hybridization was carried out using 10 μg of RNA prepared from tissues.
hLEDGF/p75 cDNA was used as a probe, and β-actin was used as an
internal control. RNA from theWT mouse and from HeLa and MT4 cells
were used as a negative control (WT), and as positive controls (Pos),
respectively. The sizes expected for hLEDGF/p75 and β-actin are indicated
by arrowheads. (B)The band intensity in (A) was measured with a BAS
2000 Bio-Image analyzer. Expression levels of hLEDGF/p75 relative to
those of β-actin are shown for each transgenic line. The threshold is
indicated by a horizontal dotted line.
examined. As shown in Figure 4A, MEF cells from hLEDGF/p75
Tg mice were prepared from mice fetuses. Tg mice were mated
with WT, and fetuses were harvested at 13.5 days of gestation
and removed embryonic internal organs from the abdominal cav-
ity. The embryos were dissociated and trypsinized to produce
single-cell suspensions. After expansion, we conﬁrmed that
hLEDGF/p75 mRNA (Figure 4B) as well as hLEDGF/p75 protein
(Figure 4C) was detected in MEF cells from the line No. 089, 110,
and 143 Tg mice.
ENHANCED NUCLEAR ACCUMULATION OF GFP-IN IN MEF CELLS FROM
hLEDGF/p75 Tg MICE
HeLa cells, andMEF cells derived from eitherWT or hLEDGF/p75
Tg mice (line No. 089, 110, and 143) were transfected with a
plasmid expressing codon-optimized IN that was N-terminally
fused to GFP, and the subcellular localization was examined by
ﬂuorescence and confocal microscopy. As shown in Figure 5A,
we observed the accumulation of GFP-IN in the nucleus of
hLEDGF/p75 Tg-derived MEF cells, making a clear contrast to
those from WT mice. To quantitatively evaluate the efﬁciency of
nuclear accumulation of GFP-IN, we classiﬁed the cells as follows;
(N) the ﬂuorescence of GFP-IN is higher in the nucleus than in
the cytoplasm; (N/C) the ﬂuorescence of GFP-IN in the nucleus
is similar to the cytoplasm; and (C) the ﬂuorescence of GFP-IN
is higher in the cytoplasm than in the nucleus (Figure 5B). As
expected, GFP-IN preferentially localized mainly into the nucleus
in HeLa cells (N: 93.1%), while GFP-IN did not localize exclu-
sively in the nucleus in WT MEF cells (N: 14.2%) but mainly
in both the cytoplasm and the nucleus in WT MEF cells (N/C:
56.7%). In contrast, GFP-IN signiﬁcantly accumulated in the
nucleus in MEF cells from line No. 089, 110, and 143 Tg mice (N:
70.8, 49.5, and 65.7, respectively; Figure 5C). These data suggest
that hLEDGF/p75 enhances IN accumulation into the nucleus of
FIGURE 4 | Preparation of MEF cells and hLEDGF/p75 expression in MEF
cells. (A) MEF cells from hLEDGF/p75Tg andWT mice were prepared from
mice fetuses. Mice were mated withWT mice, and the resulting fetuses were
harvested at 13.5 days of gestation. Embryonic internal organs were removed
from the abdominal cavity. The embryos were dissociated and trypsinized to
produce single-cell suspensions. After expansion, the expression of
hLEDGF/p75 in MEF cells was analyzed. (B) Real-time RT-PCR was performed
to evaluate the hLEDGF/p75 mRNA expression in hLEDGF/p75Tg MEF cells
by using hLEDGF/p75 speciﬁc primers. The copy numbers were normalized
with that of GAPDH. (C)Western blotting was carried out using proteins from
Tg andWT MEF cells. An anti-hLEDGF/p75 antibody was used to detect the
protein, and β-actin was detected as an internal control.
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FIGURE 5 | Subcellular localization of GFP-IN in MEF cells. (A) HeLa
and MEF cells were transfected with a plasmid expressing GFP-IN
(green). After 48 h, cells were ﬁxed and visualized by a confocal
ﬂuorescence microscopy. A typical distribution of GFP ﬂuorescence is
shown in MEF cells from different Tg lines. Hoechst (blue) was used to
stain nuclear DNA. HeLa and WT MEF cells were used as a positive and
negative control, respectively. (B) GFP positive cells were classiﬁed as
follows; N, the ﬂuorescence of GFP-IN is higher in the nucleus than in
the cytoplasm; N/C, the ﬂuorescence of GFP-IN in the nucleus is similar
to the cytoplasm; and C, the ﬂuorescence of GFP-IN is higher in the
cytoplasm than in the nucleus. (C) GFP positive cells classiﬁed by (B)
were quantiﬁed by counting approximately 100 cells.
mouse cells, probably by stably tethering the viral protein to chro-
matin as previously reported (Maertens et al., 2003; Llano et al.,
2004b; Emiliani et al., 2005; Vanegas et al., 2005; Turlure et al.,
2006).
THE SUSCEPTIBILITY OF hLEDGF/p75 Tg MEF CELLS TO HIV-1 INFECTION
Finally, we examined the susceptibility of MEF cells from
hLEDGF/p75 Tg mice to HIV-1 infection. Tg (line No. 089, 110,
and 143),WT, and LEDGF/p75 knockout MEF cells were infected
with VSV-G-pseudotyped NL4-3 viruses, and then compared the
efﬁciency of HIV-1 infection.We found that hLEDGF/p75TgMEF
cells were signiﬁcantly more susceptible to HIV-1 than WT and
mLEDGF/p75 knockout MEF cells (Figure 6). It should be noted
that the poor susceptibility of WT MEF cells to HIV-1 infection
was almost equivalent to that of the mLEDGF/p75 knockout
cells (Figure 6, left bar). Taken altogether, we conclude that
hLEDGF/p75 is able to relieve the species barrier against HIV-
1 infection in mouse cells by supporting HIV-1 PIC accumulation
into the nucleus.
DISCUSSION
Pleiotropic functions of hLEDGF/p75 were suggested in HIV-1
infection including promotion of nuclear accumulation of PIC
(Cherepanov et al., 2003, 2004; Maertens et al., 2003; Llano et al.,
2004b; Ciufﬁ et al., 2005; Vanegas et al., 2005; Van Maele et al.,
2006), selection of HIV-1 integration sites and enhancement of
proviral integration (Bukrinsky, 2004; Llano et al., 2004a, 2006a;
Emiliani et al., 2005).We previously showed that one of the species
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FIGURE 6 | Susceptibility of hLEDGF/p75Tg MEF cells to HIV-1
infection. MEF cells derived from hLEDGF/p75Tg,WT and LEDGF
knockout (KO) mice were infected with an equivalent dose of VSV-G
pseudotyped HIV-1 luciferase reporter virus. After 48 h, cells were lysed
and subjected to luciferase assay. The data shown are the mean ± SD of
triplicate experiments.*P < 0.05, **P < 0.01 (t-test).
barriers resides at the PIC nuclear accumulation step in mouse
cells and that this restriction was caused by a dysfunction of the
IN-dependent PIC accumulation system (Tsurutani et al., 2007).
In this study, we have generated 9 Tg mouse lines carrying
hLEDGF/p75, to elucidate the role of LEDGF/p75 in the nuclear
accumulation of IN. Among them, mice from line No. 089, 110,
and 143 expressed hLEDGF/p75 in the thymus, spleen, lymph
nodes and MEF cells. We found that the nuclear accumulation
of HIV-1 IN in hLEDGF/p75 Tg MEF cells was greatly enhanced.
Under these assay conditions, GFP-INwas less frequently localized
to the nucleus in WT MEF cells. These results are consistent with
the efﬁciency of luciferase expression after infection with HIV-1
pseudoviruses carrying a luciferase gene (Figure 6), suggesting
that LEDGF/p75 is one of the host factors responsible for the
HIV-1 species barrier.
The homology between hLEDGF/p75 and mLEDGF/p75 is
high (92.3% amino acid identity). LEDGF/p75 is composed of
four functional domains, theN-terminal Pro-Trp-Trp-Prodomain
(residues 1–93), the C-terminal IN-binding domain (residues
347–429), the nuclear localization signal and the AT-hook DNA-
binding motif (Maertens et al., 2003; Cherepanov et al., 2004,
2005; Vanegas et al., 2005; Llano et al., 2006a,b). The amino acid
identity of these domains and motifs are completely matched
between mouse and human LEDGF/p75. Therefore, it is likely
that the species barrier in mouse cells might be caused by
only small structural differences of previously underappreciated
regions between mouse and human LEDGF/p75 proteins.
Shun et al. (2007) previously reported that HIV-1 integration
was severely reduced in mLEDGF/p75 knockout mouse cells, sug-
gesting that mLEDGF/p75 is able to support HIV-1 infection. In
contrast, our data showed that the level of viral infectivity in
WT MEF cells was almost equivalent to that in mLEDGF/p75
knockout cells used in the above report (Shun et al., 2007),
rather suggesting that the mouse version might not contribute
to the infection (Figure 6). This discrepancy might be due to
the fact that our WT MEF cells are derived from the C3H/HeN
mouse strain while mLEDGF/p75 knockout cells are derivatives
of C57BL/6 mice. This needs to be elucidated with further exper-
iments by comparison of different mouse strains. It should be
noted that strain-speciﬁc epigenetic differences in mice, such as
methylation patterns, have recently been reported (Schilling et al.,
2009).
Small animal models for HIV-1 infection such as
Rag2−/−/Il2rg−/− mice (Traggiai et al., 2004) and BLT mice
(Denton et al., 2008) have made signiﬁcant contributions to our
understanding of HIV/AIDS pathogenesis. However, the former
mice show insufﬁcient induction of an immune response against
HIV-1 (Baenziger et al., 2006;An et al., 2007),while the use of latter
mice has been inﬂuenced by some ethical restrictions and limited
availability. On the other hand, immunologically intact transgenic
mouse models are relatively straightforward and inexpensive, in
which high levels of target gene expression can be easily achieved
resulting in an obvious phenotype.
To generate humanized mouse models for HIV-1 infection,
so far we have generated hCD4/hCXCR4/hCycT1 Tg mice and
hCD4/hCCR5/hCycT1 Tg mice (Tsurutani et al., 2007). The
addition of hLEDGF/p75 to these Tg mice should increase the
susceptibility of these mice to HIV-1 infection, especially during
the early phase of infection. However, we also need to pay atten-
tion to other host factors that restrict HIV-1 infection in mice,
such as APOBEC3, which is an APOBEC-related cytidine deam-
inases (Kobayashi et al., 2004), because these inhibitors are also
active in mouse cells (Yu et al., 2003; Kobayashi et al., 2004; Mous
et al., 2012). Further characterization and identiﬁcation of factors
involved in host range barriers that are also present in the late
phase of the viral replication cycle (transcription, RNA, export,
and virion budding) should provide a new insight into themolecu-
larmechanisms of HIV-1 replication and clues to the development
of new therapeutics.
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